Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG: NKT cells: facts, functions and fallacies. Immunol Today. 2000, 21: 573-583. 10.1016/S0167-5699(00)01735-7.
Article
CAS
PubMed
Google Scholar
Lee PT, Benlagha K, Teyton L, Bendelac A: Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med. 2002, 195: 637-641. 10.1084/jem.20011908.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gumperz JE, Miyake S, Yamamura T, Brenner MB: Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med. 2002, 195: 625-636. 10.1084/jem.20011786.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wilson MT, Singh AK, Van Kaer L: Immunotherapy with ligands of natural killer T cells. Trends Mol Med. 2002, 8: 225-231. 10.1016/S1471-4914(02)02325-0.
Article
CAS
PubMed
Google Scholar
Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M: CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 1998, 188: 1521-1528. 10.1084/jem.188.8.1521.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nieda M, Nicol A, Koezuka Y, Kikuchi A, Takahashi T, Nakamura H, Furukawa H, Yabe T, Ishikawa Y, Tadokoro K, et al: Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum Immunol. 1999, 60: 10-19. 10.1016/S0198-8859(98)00100-1.
Article
CAS
PubMed
Google Scholar
Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L: Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol. 1999, 163: 2373-2377.
CAS
PubMed
Google Scholar
Burdin N, Brossay L, Kronenberg M: Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol. 1999, 29: 2014-2025. 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G.
Article
CAS
PubMed
Google Scholar
Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, et al: Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature. 1998, 391: 177-181. 10.1038/34419.
Article
CAS
PubMed
Google Scholar
van der Vliet HJ, von Blomberg BM, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, Polman CH, Rustemeyer T, Lips P, van den Eertwegh AJ, et al: Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol. 2001, 100: 144-148. 10.1006/clim.2001.5060.
Article
CAS
PubMed
Google Scholar
Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T: Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001, 44: 1127-1138. 10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W.
Article
CAS
PubMed
Google Scholar
Araki M, Kondo T, Gumperz JE, Brenner MB, Miyake S, Yamamura T: T(h)2 bias of CD4(+) NKT cells derived from multiple sclerosis in remission. Int Immunol. 2003, 15: 279-288. 10.1093/intimm/dxg029.
Article
CAS
PubMed
Google Scholar
Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L: Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001, 194: 1801-1811. 10.1084/jem.194.12.1801.
Article
PubMed Central
CAS
PubMed
Google Scholar
Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V: Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med. 2001, 194: 1789-1799. 10.1084/jem.194.12.1789.
Article
PubMed Central
CAS
PubMed
Google Scholar
Furlan R, Bergami A, Cantarella D, Brambilla E, Taniguchi M, Dellabona P, Casorati G, Martino G: Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur J Immunol. 2003, 33: 1830-1838. 10.1002/eji.200323885.
Article
CAS
PubMed
Google Scholar
Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, et al: The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001, 7: 1052-1056. 10.1038/nm0901-1052.
Article
CAS
PubMed
Google Scholar
Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, et al: Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med. 2001, 7: 1057-1062. 10.1038/nm0901-1057.
Article
CAS
PubMed
Google Scholar
Okai M, Nieda M, Tazbirkova A, Horley D, Kikuchi A, Durrant S, Takahashi T, Boyd A, Abraham R, Yagita H, et al: Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sang. 2002, 83: 250-253. 10.1046/j.1423-0410.2002.00217.x.
Article
CAS
PubMed
Google Scholar
VanderBorght A, Geusens P, Raus J, Stinissen P: The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum. 2001, 31: 160-175. 10.1053/sarh.2001.27736.
Article
CAS
PubMed
Google Scholar
Moots RJ: A fistful of T cells. Br J Rheumatol. 1998, 37: 602-611. 10.1093/rheumatology/37.6.602.
Article
CAS
PubMed
Google Scholar
Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: systemic abnormalities-local disease. Curr Opin Rheumatol. 1999, 11: 210-217. 10.1097/00002281-199905000-00010.
Article
CAS
PubMed
Google Scholar
Kusaba M, Honda J, Fukuda T, Oizumi K: Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol. 1998, 25: 1466-1471.
CAS
PubMed
Google Scholar
Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S: Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 2004, 50: 305-313. 10.1002/art.11489.
Article
CAS
PubMed
Google Scholar
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.
Article
CAS
PubMed
Google Scholar
van der AA, Hellings N, Bernard CC, Raus J, Stinissen P: Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls. J Neuroimmunol. 2003, 137: 164-176. 10.1016/S0165-5728(03)00048-1.
Article
Google Scholar
VanderBorght A, van der AA, Geusens P, Vandevyver C, Raus J, Stinissen P: Identification of overrepresented T cell receptor genes in blood and tissue biopsies by PCR-ELISA. J Immunol Methods. 1999, 223: 47-61. 10.1016/S0022-1759(98)00201-4.
Article
CAS
PubMed
Google Scholar
Van Kaer L: Natural killer T cells as targets for immunotherapy of autoimmune diseases. Immunol Cell Biol. 2004, 82: 315-322. 10.1111/j.0818-9641.2004.01252.x.
Article
CAS
PubMed
Google Scholar
Hammond KJ, Godfrey DI: NKT cells: potential targets for autoimmune disease therapy?. Tissue Antigens. 2002, 59: 353-363. 10.1034/j.1399-0039.2002.590501.x.
Article
CAS
PubMed
Google Scholar
Wilson MT, Van Kaer L: Natural killer T cells as targets for therapeutic intervention in autoimmune diseases. Curr Pharm Des. 2003, 9: 210-220. 10.2174/1381612033392080.
Article
Google Scholar
Maeda T, Keino H, Asahara H, Taniguchi M, Nishioka K, Sumida T: Decreased TCR AV24AJ18+ double-negative T cells in rheumatoid synovium. Rheumatology (Oxford). 1999, 38: 186-188.
Article
CAS
Google Scholar
Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T: Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol. 2000, 164: 4375-4381.
Article
CAS
PubMed
Google Scholar
Matsuda JL, Gapin L, Fazilleau N, Warren K, Naidenko OV, Kronenberg M: Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc Natl Acad Sci USA. 2001, 98: 12636-12641. 10.1073/pnas.221445298.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kojo S, Tsutsumi A, Goto D, Sumida T: Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis. J Rheumatol. 2003, 30: 2524-2528.
CAS
PubMed
Google Scholar
Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM: T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 2000, 97: 9203-9208. 10.1073/pnas.97.16.9203.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wilson MT, Johansson C, Olivares-Villagomez D, Singh AK, Stanic AK, Wang CR, Joyce S, Wick MJ, Van Kaer L: The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA. 2003, 100: 10913-10918. 10.1073/pnas.1833166100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fujii S, Shimizu K, Kronenberg M, Steinman RM: Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol. 2002, 3: 867-874. 10.1038/ni827.
Article
CAS
PubMed
Google Scholar
Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, Strominger JL, Brenner MB, Gumperz JE, Wilson SB, et al: CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol. 2003, 171: 2571-2580.
Article
CAS
PubMed
Google Scholar